701-1239

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2014-01-11

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-20 (study day 10.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2014-01-20 (study day 10.0); relationship: PROBABLE

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 2.0); relationship: POSSIBLE

moderate assessed

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 2.0); relationship: POSSIBLE

mild assessed

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03; relationship: REMOTE

mild assessed

Mild HORDEOLUM — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04; relationship: NONE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-13 (study day 3.0); relationship: POSSIBLE

mild assessed

Mild SKIN ODOUR ABNORMAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 2.0); relationship: REMOTE

mild assessed

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-20 (study day 41.0); relationship: NONE

mild assessed

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2014-02-20 (study day 41.0); relationship: NONE

Data queries

No data queries.